{"name":"Timothy Yu","slug":"timothy-yu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPMUtqbFAtOWV3TmctbzUzdlZPeUlvbW16TkZDR0h1bjdtVVR3bFJUTzNycEdZSEhVUUVJeTVhUUFpSmJ3dU9ObEZVSmpzN2NCWDBJQk5yMkdQVGY0bHQxY2g0NUtZYlBRQ2gxUmN3QlFwQ0NXNTduWENQSWZRYThBWGk4OXZhcUR1b3hCNmhGOF9sREstZGMxSDhDMk11VGlxY2lWV21EaXlpM3BUbkE?oc=5","date":"2026-03-04","type":"regulatory","source":"C&EN","summary":"FDA says it wants individualized medicines. Can we get there? - C&EN","headline":"FDA says it wants individualized medicines. Can we get there? - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE02cDNKZHVRNUk4NDVKNFJ3UmQ2WE1vTV9CaXF4Vm9OZVFoOHhybkRRM25zWFpwVGFHZVNId3VOc3VDSEdIcXR5eXhFTWtCemZaM3JfRDByei1HUQ?oc=5","date":"2024-09-09","type":"pipeline","source":"Fierce Pharma","summary":"Timothy Yu - Fierce Pharma","headline":"Timothy Yu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE80Uzlfb3RXMmtOYnVpSVAyYlZ4N2ZoQXRnM05IOG5qcWYtRWRBaWZxVnpMaDlkbXlsSmlJM0oyRGlmNHNUd1FzVjU3OTZZRHFTUlh0MXkxWjBpZU03R2Vjb20zR3k?oc=5","date":"2024-09-09","type":"pipeline","source":"Fierce Pharma","summary":"Fierce 50 of 2024 - Fierce Pharma","headline":"Fierce 50 of 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPMnVGd3BrV01CX0NuYVhpMEVnT3NNUXZwU192dGRBUWZrYk12dXRLalFWU1J3R19uMFR4eXlYckVZalJvSUNGcWNHMDBQNEFORjFqUk1QWEcwNWlLaGtDUFhxbk5RSXNucVoyTDZ0b2h5aGd2bUFvUkdaem1uRU5BTzlleFVCY2V0dmoydmdOZDlNSjZMV2cwcGhpWVdaRVQzeWxkdzV0a3dYWjI3WVAyckxpZlVndjU4SHNB?oc=5","date":"2024-08-07","type":"pipeline","source":"BioSpace","summary":"Biopharma Entrepreneurs Make Business Case for Personalized Genetic Medicines - BioSpace","headline":"Biopharma Entrepreneurs Make Business Case for Personalized Genetic Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOdUdEVGZVazNwZVpnUUprS0lTTVJadkg2R29faGVjVnRRNTN2dk50VWpOOURVdTFPcFBncGlxbTgyTTJWQmxJS2ZoWi1EVzBCQzZkNWtMcWZaZEFlU3dNRzRxYUhEeVhFdlRQc3BTMTZ6Yzl5M1dhX1BCeDZDN0pDUXZJSlllcVBiOUVkbzhUUGxUdFZLMVQ5T3FReTRqZVdYMGVBM3ZzZTZZMU9EQk1vMQ?oc=5","date":"2024-07-10","type":"pipeline","source":"C&EN","summary":"Start-up aims to make personalized medicines. Is it scalable? - C&EN","headline":"Start-up aims to make personalized medicines. Is it scalable? - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPR2FpaUtGZ3JZYm1rQkdXbE03d2lSV2N0TWRZTzFQU0c0WFVwb2QxekNhejdlNkhFUVZJaXMwRFJqdzFCemdsWjEyX2ZZZE5QVmlKQ3ViLWItdFNSRTNJSG5zLVIyUkh6U25PSkZjSlhfMWVhXzdxWWFzcVBYbDJ0Tl9HeDdzbVBHdEpfZ0tEUjNhTkpwenZXVG82ekJxc3Y3QzNXaUpROF9FSkUtVVE?oc=5","date":"2024-01-18","type":"pipeline","source":"CBS News","summary":"Boston Children's Hospital lab trying to develop drug to treat boy's deadly rare disease - CBS News","headline":"Boston Children's Hospital lab trying to develop drug to treat boy's deadly rare disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPY3lhZHExTVJtTmp3SzJqaTdOWmlka2xHdDJCb0ZMMU11SXpjNk0tRS1ic1VaLTUyMjNSODdOLW9zSmlxS1ozQ1ZHU2Q4a0dSM3g4QlBxUlpGejJsZEZvTFN4MWtmcDg5YkNrNl92cmxDZHpmWnlZSExZcnBnRkN5MDF3NFFZUQ?oc=5","date":"2023-07-12","type":"pipeline","source":"statnews.com","summary":"A young girl’s custom gene therapy hints at a framework for tailored rare disease treatments - statnews.com","headline":"A young girl’s custom gene therapy hints at a framework for tailored rare disease treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE04eUZ3N2hHMzBhQWZQdTR5WF9hNHRBM3JVNFFoR1ZSa2NaaDlEOVUyNDdPdnhxVlJFLXplSnRNS2J6dzJENzY5VTZ1SzRYN2d5aHNoS1BTRFk5S1BpS0Zr?oc=5","date":"2023-07-12","type":"pipeline","source":"Nature","summary":"A framework for individualized splice-switching oligonucleotide therapy - Nature","headline":"A framework for individualized splice-switching oligonucleotide therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNQnJqb3UyRVV5akhKNk9sQ05ZbTVmMl9LQ2pWQzV6S3FJVV9HZ1QzQUdld1JkNWZRc2RSQURsVzlOeWFOMG9zeE9VQ0FtM2dXUEZJcXRkQ1NjRllmd1RmZzUtcU13dDdheTBOb2puZEtXZkgyT3BXeWZkQUVKdWRDRDRhYWo1UU02cTJCZ3Y4cHI3MFFmRTE5RVVfaWVMdw?oc=5","date":"2023-03-10","type":"deal","source":"Harvard Medical School","summary":"Collaboration Propels Research on Untreatable Neurodegenerative Disease - Harvard Medical School","headline":"Collaboration Propels Research on Untreatable Neurodegenerative Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOZzFzRjY0SWYwTmlHSGNWTFI5SnY4X1JKWUFaSk1oNTVWTGd3U2hERFdoVVU4MG0xakhZNTZKRGhGZWxuVk1NM1pzLUVyX0VwVmJHRmJvWGNrMmFGVGdqaTJzcGhmcXE2R1IzV1FVLXc2WmJLRXdLVDFiWklDUlhhTGNSeUxBTnBmb0JjMmxDWQ?oc=5","date":"2022-10-26","type":"pipeline","source":"The New York Times","summary":"Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Children (Published 2022) - The New York Times","headline":"Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Children (Published 2022)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1kUXZQZ2ZXdDkwbU5oeklRWXZ0c2lBa2NIYnFUVVM5bnFvNzFsNmpUS1Z4ZDlxX2Q3anNOV2hUN1RCS3lfcDdFZ2hvMnpDZHo0SFlhYVkyanZqWGY4dVNtdw?oc=5","date":"2019-10-24","type":"pipeline","source":"NEJM","summary":"Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease - NEJM","headline":"Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA5d3Y3NGdyOEVPTFhHMnR5T3ppejNBTm1uLWlmTjBXaUdLQUl4N25PWWJjMUhCdlBCSy1xUHdrZzBxN0JKQk5NZHh4dFRHNFZPcFJiRDQ3MDN5ZVF1YWdwTEtyVGFXLXRCVk1YX1Vn?oc=5","date":"2019-10-10","type":"pipeline","source":"Boston Children's Answers","summary":"Milasen: Genetic diagnosis to custom drug, in under 1 year - Boston Children's Answers","headline":"Milasen: Genetic diagnosis to custom drug, in under 1 year - Boston Children's Answers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}